Ligandability of E3 Ligases for Targeted Protein Degradation…
Well Cited
132
Citations107
Refs2021
Year
Search Works
Work Details
- DOI 10.1021/acs.biochem.1c00464
- PMID https://pubmed.ncbi.nlm.nih.gov/34473924
- PMCID https://www.ncbi.nlm.nih.gov/pmc/articles/8928483
- OpenAlex ID W3197828497
- Type Review
- Language EN
- Published 02 Sep 2021
- Volume 62 (3)
- Pages 588–600
- Source Biochemistry
- Publisher American Chemical Society
- FWCI 2.02
- Countries 1
- Institutions 2
- Added 13 Sep 2021
- Updated 31 Oct 2026
External Links
MENU
0
Ligandability of E3 Ligases for Targeted Protein Degradation Applications
Review 2021 EN Green
Targeted protein degradation (TPD) using proteolysis targeting chimeras (PROTACs) and molecular glue degraders has arisen as a powerful therapeutic modality for eliminating disease-causing proteins from cells. PROTACs and molecular glue degraders employ heterobifunctional or monovalent small molecules, respectively, to chemically induce the proximity of target proteins with E3 ubiquitin ligases to…
132
Citations
107
References
3
Authors
2.02
FWCI
Citations by Year
Last 5 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
3 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Bridget P. Belcher | Innovative Genomics Institute (US) University of California, Berk… (US) | |
| 2 | Carl C. Ward | Innovative Genomics Institute (US) University of California, Berk… (US) | |
| 3 | Daniel K. Nomura Corresponding | Innovative Genomics Institute (US) University of California, Berk… (US) |
Related Works
10Data: OpenAlex